Correlation Between DiaMedica Therapeutics and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Effector Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Effector Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DiaMedica and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Effector Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Effector Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.48 times more return on investment than Effector Therapeutics. However, DiaMedica Therapeutics is 2.08 times less risky than Effector Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 131.00 in DiaMedica Therapeutics on August 24, 2024 and sell it today you would earn a total of 287.00 from holding DiaMedica Therapeutics or generate 219.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 80.04% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Effector Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
DiaMedica Therapeutics and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Effector Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |